Evidence map›Paper›PMID 7539926›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1995

Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression.

J Sun, J Thurin, H S Cooper, P Wang, M Mackiewicz, Z Steplewski, M Blaszczyk-Thurin

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Tumor-Associated Glycans as Targets for Immunotherapy: The Wistar Institute Experience/Legacy.Monoclonal antibodies in immunodiagnosis and immunotherapy · 2021
    Review
  3. Article
  4. Article
  5. Gene expression profiling reveals upregulated FUT1 and MYBPC1 in children with pancreaticobiliary maljunction.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Cell surface fucosylation does not affect development of colon tumors in mice with germline Smad3 mutation.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2007
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J SunWistar Institute of Anatomy and Biology, Philadelphia, PA 19104-4268, USA.
J Thurin
H S Cooper
P Wang
M Mackiewicz
Z Steplewski
M Blaszczyk-Thurin
The Wistar Institute · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
TUMOR-ASSOCIATED FUCOSYLTRANSFERASER01CA045363 · NCI · WISTAR INSTITUTE · PI BLASZCZYK-THURIN, MAGDALENA · 1988 to 1992
–
ISCOM GLYCOSIDE ADJUVANT AND HIV-1 VACCINEU01AI028679 · NIAID · WISTAR INSTITUTE · PI THURIN, JAN · 1989 to 1991
–
NCI NIH HHS CA10815NCI NIH HHS CA45363NIAID NIH HHS AI28679
6 · The paper itself

Abstract

GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase (EC 2.4.1.69) is a key enzyme in the biosynthesis of fucosylated type 1 and 2 lactoseries structures, such as Lewis b and the H type 2 and Lewis Y, respectively, that are accumulated in colon adenocarcinoma. Analysis of the mRNA transcript level for the human H gene-encoded beta-D-galactoside alpha-2-L-fucosyltransferase revealed 40- and 340-fold increases in the mRNA levels in all adenocarcinomas and tumor cell lines, respectively, compared to normal colon mucosa where a low level of mRNA transcript was detected. A variable increase in mRNA transcript levels was observed in 50% of adenomatous polyps. Nucleotide sequence analysis of the protein coding region of the cDNAs derived from normal colon, adenoma, and colon adenocarcinoma revealed 100% homology, suggesting that there are no tumor-associated allelic variations within the H beta-D-galactoside alpha-2-L-fucosyltransferase cDNA. These results suggest that beta-D-galactoside alpha-2-L-fucosyltransferase expression highly correlates with malignant progression of colon adenocarcinoma.

Indexed as

AdenocarcinomaAnimalsBase SequenceCarbohydratesCloning, MolecularColonic NeoplasmsDisease ProgressionDNA, ComplementaryDNA PrimersEpitopesFucosyltransferasesGalactoside 2-alpha-L-fucosyltransferaseHumansMolecular Sequence DataPolymerase Chain ReactionRNA, MessengerCarbohydratesDNA, ComplementaryDNA PrimersEpitopesFucosyltransferasesGalactoside 2-alpha-L-fucosyltransferaseRNA, Messenger

Identifiers

PMID7539926
PMCPMC41769
OpenAlexW2082071495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.